XML 54 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
The Company recorded stock-based compensation expense in the following expense categories of its accompanying audited statements of operations and comprehensive loss (in thousands):
Year Ended December 31,
20232022
Research and development$3,462 $3,574 
General and administrative3,477 2,888 
Total stock-based compensation$6,939 $6,462 
Schedule of option activity
The following table summarizes option activity under the 2020 Plan:
Options
Weighted
Average
Exercise Price
Weighted
Average
Remaining Life
(Years)
Balance at December 31, 2022
4,209,255 $8.29 8.07
Granted1,462,535 3.41 
Exercised(135,254)3.26 
Forfeited(594,372)6.41 
Balance at December 31, 2023
4,942,164 $7.21 7.62
Vested and expected to vest4,787,518 $7.27 7.47
Exercisable at the end of the period2,696,018 $8.34 6.47
Schedule of RSU activities
The following table summarizes employee RSU activity for the year ended December 31, 2023:
Awards
Weighted
Average
Grant Date Fair Value
Unvested RSUs at December 31, 2022
309,477 $7.22 
Granted460,925 3.54 
Vested(77,312)7.22 
Forfeited(102,687)4.62 
Balance at December 31, 2023
590,403 $4.80 
Schedule of valuation assumptions
The grant-date fair value of options calculated using the Black-Scholes option pricing model granted under the Company’s 2020 Plan were estimated using the following weighted-average assumptions:
Year Ended December 31,
2023
2022
2020 Plan
Expected term - years6.086.08
Expected volatility84.8 %82.4 %
Risk-free interest rate3.6 %2.4 %
Expected dividends— — 
The grant-date fair value of options calculated using the Monte Carlo option pricing model granted under the Company’s 2020 Plan were estimated using the following assumptions:
Year Ended December 31,
20232022
2020 Plan
Expected term - years4.004.00
Expected volatility80.0 %80.0 %
Risk-free interest rate3.6 %1.4 %
Expected dividends— — 
The grant-date fair value of shares issued calculated using the Black-Scholes option pricing model under the Company’s 2020 ESPP were estimated using the following weighted-average assumptions:
Year Ended December 31,
2023
2022
2020 ESPP
Expected term - years0.50.5
Expected volatility85.5 %82.9 %
Risk-free interest rate4.0 %2.5 %
Expected dividends— —